Can Tumor Necrosis Factor Inhibitors Protect Rheumatoid Arthritis Patients from Osteoporosis? Impact of Tumor Necrosis Factor Inhibitors on Bone Mineral Density and Bone Remodeling Markers.

被引:0
|
作者
Nutz, Anaiz [1 ]
Duny, Yohan [2 ]
Barnetche, Thomas [3 ]
Morel, Jacques [1 ]
Combe, Bernard [1 ]
Daien, Claire [1 ]
机构
[1] Hop Lapeyronie, Montpellier, France
[2] INSERM, Montpellier, France
[3] Dept Rheumatol, Bordeaux, France
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1490
引用
收藏
页码:S656 / S656
页数:1
相关论文
共 50 条
  • [1] THE EFFECT OF LONG-TERM THERAPY OF TUMOR NECROSIS FACTOR INHIBITORS ON MINERAL BONE DENSITY IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Jankovic, T.
    Zvekic-Svorcan, J.
    Mikov, A.
    Krasnik, R.
    Vuklis, D.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2020, 31 (SUPPL 1) : S145 - S145
  • [2] Tumor necrosis factor inhibitors for rheumatoid arthritis
    Dentener, Mieke A.
    Wouters, Emiel F. M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (19): : 2047 - 2048
  • [3] Tumor necrosis factor inhibitors for rheumatoid arthritis
    Scott, D. L.
    Kingsley, G. H.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (07): : 704 - 712
  • [4] Inhibitors of tumor necrosis factor for rheumatoid arthritis
    Moreland, LW
    [J]. JOURNAL OF RHEUMATOLOGY, 1999, 26 : 7 - 15
  • [5] Tumor necrosis factor inhibitors for rheumatoid arthritis
    Jones, RE
    Moreland, LW
    [J]. BULLETIN ON THE RHEUMATIC DISEASES, 1999, 48 (03) : 1 - 4
  • [6] CHANGES IN BONE BIOCHEMICAL MARKERS DUE TO THE INFLUENCE OF RISK FACTORS FOR OSTEOPOROSIS IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH TUMOR NECROSIS FACTOR INHIBITORS
    Jankovic, T.
    Svorcan, J. Zvekic
    Boskovic, K.
    Savic, A.
    Glavcic, A.
    Minakovic, I.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1408 - 1409
  • [7] Tumor necrosis factor inhibitors for rheumatoid arthritis - Reply
    Scott, D. L.
    Kingsley, G. H.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (19): : 2048 - 2048
  • [8] Predictors of discontinuation of tumor necrosis factor inhibitors in patients with rheumatoid arthritis
    Agarwal, Sandeep K.
    Glass, Roberta J.
    Shadick, Nancy A.
    Coblyn, Jonathan S.
    Anderson, Ronald J.
    Maher, Nancy E.
    Weinblatt, Michael E.
    Solomon, Daniel H.
    [J]. JOURNAL OF RHEUMATOLOGY, 2008, 35 (09) : 1737 - 1744
  • [9] Impact of Stopping Tumor Necrosis Factor Inhibitors on Rheumatoid Arthritis Patients' Burden of Disease
    Moghadam, Marjan Ghiti
    ten Klooster, Peter M.
    Vonkeman, Harald E.
    Kneepkens, Eva L.
    Klaasen, Ruth
    Stolk, Jan N.
    Tchetverikov, Ilja
    Vreugdenhil, Simone A.
    van Woerkom, Jan M.
    Goekoop-Ruiterman, Yvonne P. M.
    Landewe, Robert B. M.
    van Riel, Piet L. C. M.
    van de Laar, Mart A. F. J.
    Jansen, Tim L.
    [J]. ARTHRITIS CARE & RESEARCH, 2018, 70 (04) : 516 - 524
  • [10] Skin cancer, rheumatoid arthritis, and tumor necrosis factor inhibitors
    Chakravarty, EF
    Michaud, K
    Wolfe, F
    [J]. JOURNAL OF RHEUMATOLOGY, 2005, 32 (11) : 2130 - 2135